# SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-2024-rbc-capital-markets-global-healthcare-con-9aa966bb
Ticker: SOPH
Company: Sophia Genetics
Source: Sophia Genetics
Published: 2024-04-30 11:05 EST
## Summary

SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine,...

## Article Body
SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced that Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City on Tuesday, May 14, 2024, at 3:35 p.m. EDT.

The presentation will be webcast live on the SOPHiA GENETICS Investor Relations website . Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn .
## Recent Company News
- 2024-06-24 13:47 EST — [SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting](https://biopharmsignal.com/news/SOPH/sophia-genetics-publishes-results-of-2024-annual-general-meeting-cd3af75f) — Source: Sophia Genetics
- 2024-05-07 10:45 EST — [SOPHiA GENETICS Reports First Quarter 2024 Results](https://biopharmsignal.com/news/SOPH/sophia-genetics-reports-first-quarter-2024-results-e1a64b37) — Source: Sophia Genetics
- 2024-04-30 11:05 EST — [SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-2024-rbc-capital-markets-global-healthcare-con-9aa966bb) — Source: Sophia Genetics
- 2024-04-23 14:29 EST — [SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-announce-financial-results-for-first-quarter-2024-on-may-7-20-f68ce487) — Source: Sophia Genetics
- 2024-03-07 17:07 EST — [SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference](https://biopharmsignal.com/news/SOPH/sophia-genetics-to-present-at-the-barclays-26th-annual-global-healthcare-confere-76cb280c) — Source: Sophia Genetics
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)